Problem being addressed[edit | edit source]
Many women in underdeveloped countries suffer from preeclampsia. Preeclampsia is a condition that typically starts after the 20th week of pregnancy and is related to increased blood pressure and protein in the mother's urine (as a result of kidney problems). Preeclampsia affects the placenta, and it can affect the mother's kidney, liver, and brain. When preeclampsia causes seizures, the condition is known as eclampsia--the second leading cause of maternal death in the U.S. Preeclampsia is also a leading cause of fetal complications, which include low birth weight, premature birth, and stillbirth.
Detailed description of the solution[edit | edit source]
It is a blood pressure monitor. This device performs pulse arrhythmia detection. It is clinically tested, very easy to use.
Designed by[edit | edit source]
- Designed by: Microlife Corporation Scientists
- Manufacturer (if different):
- Manufacturer location:
When and where it was tested/implemented[edit | edit source]
Funding Source[edit | edit source]
References[edit | edit source]
Peer-reviewed publication[edit | edit source]
Other internally generated reports[edit | edit source]
Externally generated reports[edit | edit source]
de Greeff A, Nathan H, Stafford N, Liu B, Shennan AH. Development of an accurate oscillometric blood pressure device for low resource settings. Blood Press Monit 2008;13:342-8.